State Laws Linked to Very Small Changes in Opioid Prescribing
MONDAY, March 14, 2022 (HealthDay News) — State laws are associated with small and non-statistically significant changes in opioid prescribing or nonopioid pain treatment, according to a study published online March 15 in the Annals of Internal Medic…
Learn MoreQuestions Remain About Safety of Aspirin Cessation in Older Adults
MONDAY, March 14, 2022 (HealthDay News) — A subgroup analysis of the ASPREE trial could not conclusively demonstrate clear harm or benefit of either cessation or continuation of aspirin in older adults who regularly use aspirin without a clinical ind…
Learn MoreChildbearing Cardiologists Experience Adverse Effects
MONDAY, March 14, 2022 (HealthDay News) — Many childbearing female cardiologists experience adverse effects in their physical health, finances, and career advancement, according to a study published in the March 22 issue of the Journal of the America…
Learn More‘Deltacron’ Variant Rare and Not a Major Concern
MONDAY, March 14, 2022 (HealthDay News) — A recently identified hybrid of the omicron and delta coronavirus variants is unlikely to become a serious threat, scientists say.The new hybrid, first found in samples collected in France in January, is form…
Learn MoreNew Malaria Treatment Gets First Approval for Use in Children
MONDAY, March 14, 2022 (HealthDay News) — A new drug that can cure a certain type of malaria was approved in Australia Monday for children and teens.The approval was announced on Monday by the nonprofit Medicines for Malaria Venture (MMV), which help…
Learn More13.4 Percent of High School Students Reported Tobacco Use in 2021
MONDAY, March 14, 2022 (HealthDay News) — During 2021, 13.4 percent of high school students and 4.0 percent of middle school students reported tobacco product use during the previous 30 days, according to research published in the March 11 issue of …
Learn MoreACR Updates Guidelines for Juvenile Idiopathic Arthritis
MONDAY, March 14, 2022 (HealthDay News) — In two 2021 American College of Rheumatology guidelines, published online March 1 in Arthritis & Rheumatology, updated recommendations are presented for the pharmacologic and nonpharmacologic management of ju…
Learn MoreAzithromycin Therapy Does Not Reduce Recurrent Wheeze After RSV
MONDAY, March 14, 2022 (HealthDay News) — Azithromycin therapy during acute severe respiratory syncytial virus (RSV) bronchiolitis does not reduce recurrent wheeze over two to four years, according to a study published online Feb. 27 in NEJM Evidence…
Learn MorePeripheral Neuropathy Observed in Patients With ‘Long COVID’
MONDAY, March 14, 2022 (HealthDay News) — Some patients with “long COVID” have incident neuropathy, according to a study published online March 1 in Neurology: Neuroimmunology & Neuroinflammation.Anne Louise Oaklander, M.D., Ph.D., from Massachusetts…
Learn MoreTreatment Strategy Studied for Drug Use-Linked Infective Endocarditis
MONDAY, March 14, 2022 (HealthDay News) — A modeling study suggests that incorporating outpatient parenteral antimicrobial therapy (OPAT) or partial oral antibiotic approaches along with addiction care services in the treatment of patients with injec…
Learn More